rs12085877
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006610.4(MASP2):c.1316G>A(p.Arg439His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00517 in 1,610,136 control chromosomes in the GnomAD database, including 375 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R439C) has been classified as Uncertain significance.
Frequency
Consequence
NM_006610.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MASP2 | NM_006610.4 | c.1316G>A | p.Arg439His | missense_variant | 11/11 | ENST00000400897.8 | NP_006601.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MASP2 | ENST00000400897.8 | c.1316G>A | p.Arg439His | missense_variant | 11/11 | 1 | NM_006610.4 | ENSP00000383690.3 |
Frequencies
GnomAD3 genomes AF: 0.0271 AC: 4126AN: 152130Hom.: 187 Cov.: 33
GnomAD3 exomes AF: 0.00714 AC: 1745AN: 244258Hom.: 74 AF XY: 0.00515 AC XY: 683AN XY: 132568
GnomAD4 exome AF: 0.00288 AC: 4195AN: 1457888Hom.: 188 Cov.: 34 AF XY: 0.00241 AC XY: 1748AN XY: 724914
GnomAD4 genome AF: 0.0271 AC: 4127AN: 152248Hom.: 187 Cov.: 33 AF XY: 0.0260 AC XY: 1932AN XY: 74426
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2018 | - - |
Immunodeficiency due to MASP-2 deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at